| Literature DB >> 27934951 |
Raphaële Castagné1,2,3, Michelle Kelly-Irving2,3, Gianluca Campanella1, Florence Guida1, Vittorio Krogh4, Domenico Palli5, Salvatore Panico6, Carlotta Sacerdote7, Rosario Tumino8, Jos Kleinjans9, Theo de Kok9, Soterios A Kyrtopoulos10, Thierry Lang2,3, Silvia Stringhini11, Roel Vermeulen1,12, Paolo Vineis1,13,14, Cyrille Delpierre2,3, Marc Chadeau-Hyam1,14.
Abstract
Consistent evidence is accumulating to link lower socioeconomic position (SEP) and poorer health, and the inflammatory system stands out as a potential pathway through which socioeconomic environment is biologically embedded. Using bloodderived genome-wide transcriptional profiles from 268 Italian participants of the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, we evaluated the association between early life, young and later adulthood SEP and the expression of 845 genes involved in human inflammatory responses. These were examined individually and jointly using several inflammatory scores. Our results consistently show that participants whose father had a manual (as compared to nonmanual) occupation exhibit, later in life, a higher inflammatory score, hence indicating an overall increased level of expression for the selected inflammatory-related genes. Adopting a life course approach, these associations remained statistically significant upon adjustment for later-in-life socioeconomic experiences. Sensitivity analyses indicated that our findings were not affected by the way the inflammatory score was calculated, and were replicated in an independent study. Our study provides additional evidence that childhood SEP is associated with a sustainable upregulation of the inflammatory transcriptome, independently of subsequent socioeconomic experiences. Our results support the hypothesis that early social inequalities impacts adult physiology.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27934951 PMCID: PMC5146729 DOI: 10.1038/srep38705
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Summary characteristics of the study population.
| Father’s occupational position (N = 226) | Participant’s education (N = 245) | Highest household occupational position (N = 229) | Participants with complete data (N = 222) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Manual | Manual | P-value | High | Low | P-value | Non Manual | Manual | P-value | |||
| N | 82 | 144 | 108 | 137 | 151 | 78 | 222 | ||||
| Age, yo | 52.5 (7.8) | 54.2 (8.3) | 1.35E-01 | 50.8 (7.2) | 55.4 (8.0) | 3.59E-06 | 52.9 (8) | 54.9 (8.2) | 8.58E-02 | 53.6 (8.1) | |
| Gender | |||||||||||
| Breast case | Women | 62 (75.6) | 101 (70.1) | 4.67E-01 | 76 (70.4) | 104 (75.9) | 4.07E-01 | 106 (70.2) | 57 (73.1) | 7.63E-01 | 160 (72.1) |
| Men | 20 (24.4) | 43 (29.9) | 32 (29.6) | 33 (24.1) | 45 (29.8) | 21 (26.9) | 62 (27.9) | ||||
| 16 (19.5) | 22 (15.3) | 5.26E-01 | 19 (17.6) | 22 (16.1) | 8.83E-01 | 29 (19.2) | 8 (10.3) | 1.20E-01 | 36 (16.2) | ||
| NHL case | 29 (35.4) | 44 (30.6) | 5.51E-01 | 33 (30.6) | 46 (33.6) | 7.15E-01 | 55 (36.4) | 21 (26.9) | 1.94E-01 | 73 (32.9) | |
| Center | |||||||||||
| South | 4 (4.9) | 17 (11.8) | 3.45E-02 | 16 (14.8) | 16 (11.7) | 2.24E-02 | 11 (7.3) | 9 (11.5) | 1.93E-01 | 19 (8.6) | |
| Central | 47 (57.3) | 59 (41.0) | 58 (53.7) | 54 (39.4) | 78 (51.7) | 31 (39.7) | 105 (47.3) | ||||
| North | 31 (37.8) | 68 (47.2) | 34 (31.5) | 67 (48.9) | 62 (41.1) | 38 (48.7) | 98 (44.1) | ||||
| Phase | |||||||||||
| Phase 1 | 62 (75.6) | 106 (73.6) | 8.63E-01 | 87 (80.6) | 98 (71.5) | 1.39E-01 | 119 (78.8) | 51 (65.4) | 4.12E-02 | 165 (74.3) | |
| Phase 2 | 20 (24.4) | 38 (26.4) | 21 (19.4) | 39 (28.5) | 32 (21.2) | 27 (36.4) | 57 (25.7) | ||||
| Body mass index | 25.3 (3.3) | 26.0 (3.6) | 1.49E-01 | 24.9 (3.1) | 26.5 (3.6) | 1.57E-04 | 25.4 (3.3) | 26.5 (3.6) | 2.94E-02 | 25.8 (3.4) | |
| Smoking status | |||||||||||
| Never | 36 (43.9) | 78 (54.5) | 2.86E-01 | 42 (38.9) | 78 (56.9) | 1.90E-02 | 68 (45.0) | 45 (57.7) | 1.58E-01 | 112 (50.5) | |
| Former | 25 (30.5) | 33 (23.1) | 35 (32.4) | 30 (21.9) | 43 (28.5) | 16 (20.5) | 58 (26.1) | ||||
| Current | 21 (25.6) | 32 (22.4) | 31 (28.7) | 29 (21.2) | 40 (26.5) | 16 (20.5) | 52 (23.4) | ||||
| Missing | 0 (0.0) | 1 (0.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.3) | 0 (0) | ||||
| Grams alcohol/day | 14.5 (20.2) | 10.6 (14.5) | 1.28E-01 | 12.6 (15.9) | 11.1 (17) | 4.79E-01 | 12.2 (15.4) | 12.6 (19.4) | 8.90E-01 | 12.1 (16.9) | |
Population features are also summarized for each SEP category.
Counts and percentages are reported for categorical variable, and means and standard deviations for continous variables.
P-value for difference was calculated using the chi-squared test for categorical variables and the Student t-test for continuous variables.
*North: Turin & Varese; Central: Florence; South: Naples & Ragusa.
Linear regression results for the inflammatory transcriptome and each of the three SEP factors in the EPIC-Italy participants from EGM (N = 222).
| Father’s occupational position | Participant’s education | Highest household occupationnal position | ||||
|---|---|---|---|---|---|---|
| P-value | P-value | P-value | ||||
| Inflammatory transcriptome score | 21.81 (10.32) | 0.036 | −0.64 (10.51) | 0.951 | 7.51 (10.78) | 0.487 |
| Principal component 1 | −4.03 (2.14) | 0.061 | −0.91 (2.17) | 0.676 | −2.36 (2.23) | 0.289 |
| Cumulative gene ranking-based score | 13.76 (6.14) | 0.026 | 4.64 (3.41) | 0.176 | 10.57 (5.61) | 0.061 |
Sensitivity analysis results are also presented for the principal component 1 and the cumulative gene ranking-based score. *Score is calculated separately for each SEP indicator. Model adjusted on age, gender, lymphoma and breast cancer case-control status, phase and center.
Figure 1(A) Boxplot of the inflammatory transcriptome for both classes of father’s occupational position. (B) Association between sub-pathway inflammatory score and father’s occupational position (model A). The −log10 p-value (left Y-axis) is signed by the direction of the effect size estimate and is given separately for of the 17 sub-pathways (X-axis). The dotted horizontal line represents the Bonferroni significance level correcting for 17 tests, and ensuring a family wide error rate of 5%. In the secondary (right) Y-axis, the number of genes contributing to each sub-pathway is represented. (C) Pairwise Spearman correlation between each of the 17 sub-pathway scores in the EPIC-Italy participants (N = 246).
Life course multiple regression analyses for father’s occupational position and the inflammatory transcriptome.
| Variables | Levels | Model A | Model B | Model C | Model D | Fully Adjusted Model | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| P-value | P-value | P-value | P-value | P-value | |||||||
| (A) Inflammatory transcriptome score | |||||||||||
| Father’s occupational position | Manual | 21.81 (10.32) | 0.036 | 26.25 (11.26) | 0.021 | 25.41 (11.39) | 0.027 | 25.37 (11.46) | 0.028 | 23.59 (11.40) | 0.040 |
| Participant’s education | Low | −11.21 (11.35) | 0.324 | −14.09 (12.61) | 0.265 | −9.81 (12.67) | 0.440 | −9.07 (12.57) | 0.472 | ||
| Highest household occupational position | Manual | 6.59 (12.49) | 0.599 | 9.14 (12.5) | 0.465 | 10.24 (12.40) | 0.410 | ||||
| BMI | −3.23 (1.53) | 0.036 | −3.30 (1.52) | 0.031 | |||||||
| Smoking status | Former | 19.23 (13.44) | 0.154 | 18.78 (13.32) | 0.160 | ||||||
| Current | 10.19 (13.33) | 0.445 | 11.44 (13.30) | 0.391 | |||||||
| Alcohol | −0.06 (0.34) | 0.868 | 0.06 (0.34) | 0.855 | |||||||
| (B) Principal components 1 | |||||||||||
| Father’s occupational position | Manual | −4.03 (2.14) | 0.061 | −4.36 (2.34) | 0.063 | −4.12 (2.36) | 0.083 | −3.93 (2.39) | 0.102 | −2.52 (2.05) | 0.219 |
| Participant’s education | Low | 0.85 (2.35) | 0.720 | 1.68 (2.62) | 0.522 | 1.42 (2.64) | 0.591 | 0.73 (2.26) | 0.746 | ||
| Highest household occupational position | Manual | −1.9 (2.59) | 0.464 | −1.98 (2.61) | 0.449 | −2.67 (2.23) | 0.232 | ||||
| BMI | 0.14 (0.32) | 0.657 | 0.22 (0.27) | 0.414 | |||||||
| Smoking status | Former | −0.61 (2.8) | 0.829 | −0.44 (2.39) | 0.854 | ||||||
| Current | 4.51 (2.78) | 0.106 | 3.10 (2.39) | 0.196 | |||||||
| Alcohol | 0.04 (0.07) | 0.535 | −0.01 (0.06) | 0.852 | |||||||
| (C) Cumulative gene ranking-based score | |||||||||||
| Father’s occupational position | Manual | 13.76 (6.14) | 0.026 | 15.6 (6.71) | 0.021 | 14.85 (6.78) | 0.030 | 14.04 (6.88) | 0.043 | 10.41 (6.12) | 0.091 |
| Participant’s education | Low | −4.63 (6.76) | 0.494 | −7.2 (7.5) | 0.338 | −5.96 (7.61) | 0.434 | −4.16 (6.75) | 0.538 | ||
| Highest household occupational position | Manual | 5.89 (7.43) | 0.429 | 6.63 (7.5) | 0.378 | 8.39 (6.66) | 0.209 | ||||
| BMI | −0.95 (0.92) | 0.304 | −1.16 (0.82) | 0.156 | |||||||
| Smoking status | Former | 2.78 (8.07) | 0.731 | 2.38 (7.16) | 0.740 | ||||||
| Current | −5.71 (8) | 0.476 | −2.00 (7.16) | 0.780 | |||||||
| Alcohol | −0.16 (0.2) | 0.435 | −0.02 (0.18) | 0.904 | |||||||
Results are presented for the inflammatory transcriptome score (A), the first PC (B) and the cumulative gene ranking-based score (C). Estimates are based on 222 participants with full SEP and lifestyle information. *Model adjusted for cell blood composition (see Methods).
Linear regression results for the inflammatory transcriptome and the early-life SEP in participants from the GSE15180 dataset.
| SES in early-life | ||||
|---|---|---|---|---|
| Model non adjusted | Adjusted for cell blood count | |||
| P-value | P-value | |||
| Inflammatory transcriptome score | 24.5 (10.21) | 0.020 | 20.21 (9.59) | 0.040 |
| Principal component 1 | −2.80 (2.86) | 0.332 | −1.23 (2.49) | 0.624 |
| Cumulative gene ranking-based score* | 4.48 (1.11) | 0.0002 | 3.68 (0.78) | 0.00002 |
Sensitivity analysis results are also presented for the principal component 1 and the cumulative gene ranking-based score.
Linear regression results for each sub-pathway score (model A and D) and father’s occupational position.
| Subpathway | Number of genes | Father’s occupational position | |||||
|---|---|---|---|---|---|---|---|
| Model A | Model D | ||||||
| SE | P-value | SE | P-value | ||||
| Cytokine signaling | 119 | 3.07 | 1.46 | 0.036 | 3.32 | 1.61 | 0.04 |
| MAPK signaling | 111 | 3.62 | 1.76 | 0.041 | 4.89 | 1.95 | 0.01 |
| Adhesion-Extravasation-Migration | 110 | 1.53 | 1.52 | 0.315 | 2.29 | 1.69 | 0.18 |
| Leukocyte signaling | 103 | 3.62 | 1.40 | 0.010 | 4.02 | 1.56 | 0.01 |
| Apoptosis Signaling | 64 | 1.50 | 1.04 | 0.149 | 1.65 | 1.16 | 0.16 |
| Phagocytosis-Ag presentation | 37 | 2.13 | 0.77 | 0.006 | 1.82 | 0.86 | 0.03 |
| G-Protein Coupled Receptor Signaling | 34 | 0.44 | 0.53 | 0.413 | 0.52 | 0.59 | 0.38 |
| Innate pathogen detection | 34 | 0.86 | 0.75 | 0.251 | 0.73 | 0.84 | 0.39 |
| PI3K/AKT Signaling | 34 | 0.56 | 0.60 | 0.357 | 0.76 | 0.67 | 0.26 |
| Eicosanoid Signaling | 32 | 0.06 | 0.50 | 0.898 | 0.09 | 0.55 | 0.88 |
| NF-kB signaling | 32 | 0.59 | 0.52 | 0.260 | 0.77 | 0.58 | 0.18 |
| TNF Superfamily Signaling | 31 | 0.78 | 0.45 | 0.084 | 1.01 | 0.49 | 0.04 |
| Natural Killer Cell Signaling | 29 | 0.99 | 0.71 | 0.161 | 1.05 | 0.79 | 0.18 |
| Complement Cascase | 27 | 0.42 | 0.48 | 0.384 | 0.40 | 0.54 | 0.45 |
| ROS/Glutathione/Cytotoxic granules | 18 | 0.68 | 0.38 | 0.076 | 0.76 | 0.42 | 0.07 |
| Glucocorticoid/PPAR signaling | 17 | 0.46 | 0.39 | 0.245 | 0.52 | 0.44 | 0.23 |
| Calcium Signaling | 13 | 0.51 | 0.32 | 0.106 | 0.78 | 0.35 | 0.03 |